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ABSTRACT The concentration profiles
of adenosine diphosphate (ADP),
thromboxane A2 (TxA2), thrombin, and
von Willebrand factor (vWF) released
extracellularly from the platelet gran-
ules or produced metabolically on the
platelet membrane during thrombus
growth, were estimated using finite ele-
ment simulation of blood flow over
model thrombi of various shapes and
dimensions. The wall fluxes of these
platelet-activating agents were esti-
mated for each model thrombus at
three different wall shear rates (100
s-', 800 s-1, and 1,500 s-1), employ-
ing experimental data on thrombus
growth rates and sizes. For that pur-
pose, whole human blood was per-
fused in a parallel-plate flow chamber
coated with type fibrillar human collag-
en, and the kinetic data collected and
analyzed by an EPI-fluorescence video
microscopy system and a digital image
processor. It was found that thrombin
concentrations were large enough to
cause irreversible platelet aggregation.
Although heparin significantly acceler-
ated thrombin inhibition by antithrombin
111, the remaining thrombin levels were
still significantly above the minimum
threshold required for irreversible
platelet aggregation. While ADP con-
centrations were large enough to
cause irreversible platelet aggregation
at low shear rates and for small aggre-
gate sizes, TxA2 concentrations were
only sufficient to induce platelet shape
change over the entire range of wall
shear rates and thrombi dimensions
studied. Our results also indicated that
the local concentration of vWF multi-
mers released from the platelet a-gran-
ules could be sufficient to modulate
platelet aggregation at low and inter-
mediate wall shear rates (<1,000 s-1).
The sizes of standing vortices
formed adjacent to a growing aggre-
gate and the embolizing stresses and
the torque, acting at the aggregate
surface, were also estimated in this
simulation. It was found that standing
vortices developed on both sides of the
thrombus even at low wall shear rates.
Their sizes increased with thrombus
size and wall shear rate, and were
largely dependent upon thrombus ge-
ometry. The experimental observation
that platelet aggregation occurred pre-
dominantly in the spaces between
adjacent thrombi, confirmed the nu-
merical prediction that those standing
vortices are regions of reduced fluid
velocities and high concentrations of
platelet-activating substances, capable
of trapping and stimulating platelets for
aggregation. The average shear stress
and normal stress, as well as the
torque, acting to detach the thrombus,
increased with increasing wall shear
rate. Both stresses were found to be
nearly independent of thrombus size
and only weakly dependent upon
thrombus geometry. Although both
stresses had similar values at low wall
shear rates, the average shear stress
became the predominant embolizing
stress at high wall shear rates.
INTRODUCTION
Blood platelets have been recognized as major contribu-
tors to the normal hemostatic mechanism as well as its
derived pathological state, thrombosis, for decades (1, 2).
Indeed, when blood platelets flow near the subendothe-
lium of an injured blood vessel (3, 4), an artificial poly-
meric surface used in a prosthetic blood-contacting device
(5), or an artherosclerotic lesion (6), a number of hemo-
rheological and biochemical events take place very
rapidly near that site to form thrombi (solid platelet
aggregates) on the reactive surface. Clinically, the com-
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plications of thrombosis occur as local obstruction of
blood vessels or distal embolization of the thrombus,
interrupting blood flow downstream, thereby limiting
oxygen transport to tissues, leading to ischemia or infarc-
tion (6).
Following initial platelet adhesion and activation on
the reactive surface, biochemical proaggregatory agents
are released extracellularly from the platelet granules or
produced metabolically on the platelet membrane. Accu-
mulating in high concentration locally at the site of
aggregate formation, these platelet-activating substances
act synergistically to activate additional platelets and
accelerate the process of thrombus growth (7). Releas-
able materials are important in normal thrombogenesis,
for platelets lacking these agents (storage pool disease),
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have been shown to have reduced thrombus formation on
subendothelium and fibrillar collagen (8).
Because the relative importance of most proaggrega-
tory substances in inducing mural thrombogenesis is still
uncertain, and because direct measurement of very low
concentrations of chemicals in a dynamic system is diffi-
cult, a two-dimensional theoretical model, involving the
simulation of blood flow between two parallel plates over
a model thrombus attached to the bottom plate, was
developed. Four potential platelet-activating agents were
investigated. Adenosine diphosphate (ADP) and von Wil-
lebrand factor (vWF) are released, respectively, from the
dense and a-granules of activated platelets, while throm-
boxane A2 (TxA2) and thrombin are enzymatically gener-
ated on or near the platelet membrane (9). For each
agent, the estimated maximum concentration in the
neighborhood of one thrombus or two adjacent thrombi
generating and releasing that compound, was compared
with the concentration known to affect platelet function
in various in vitro measurement systems.
Because the local concentration profiles of releasable
substances depend primarily on the rate of thrombus
growth or the thrombus size, and on the rate of transport
of those substances from the aggregate site, concentration
profiles were computed as a function of wall shear rate.
This is the main fluid mechanical variable controlling
surface access. Indeed, blood flow greatly increases the
effective diffusivity of cells and proteins, through a red
blood cell (RBC) rotation and/or an interparticle colli-
sion mechanism, in a shear rate dependent manner (10).
Because the thrombogenesis process occurs near the
surface where the local concentration of RBCs is low, the
increased diffusivity is predominantly due to the rotation
of RBCs in a shear field, and Keller's mixing model
(1 1, 12) was used to estimate the enhanced diffusivities of
platelet-activating agents in whole blood.
An EPI-fluorescence video microscopy system, coupled
with digital image processing techniques, was utilized to
determine experimentally the rates of growth and sizes of
individual thrombi at different wall shear rates, ranging
from 100 s-' (a typical venous shear rate) to 1,500 s-' (an
arterial shear rate). Whole human blood was perfused in
a parallel-plate flow chamber coated with human col-
lagen type I fibrils, a predominant thrombogenic protein
found in the subendothelium of injured blood vessels (13).
The data obtained in those experiments were then used in
the mathematical model to estimate the wall fluxes of
platelet-activating agents at various wall shear rates.
Only two papers using similar microscopic modelling
have been reported in the literature. The first one used
only a qualitative approach to determine the approximate
shapes of the concentration contours generated (14). The
second one, from our laboratory, did investigate the role
of several platelet-activating substances in promoting
thrombus growth, but using a one-dimensional model of a
flat thrombus, and ignoring the presence of RBCs (15).
Consequently, neither the flow disturbances caused by
the finite size of the growing platelet aggregates nor the
effect of shear rate on the magnitude of the wall flux of
platelet-activating agents were considered.
The purpose of the present paper is, therefore, to
estimate computationally the concentration profiles of
four proaggregatory compounds (ADP, TxA2, thrombin,
vWF) released from a more realistic model thrombus,
thereby gaining some insight into which platelet-activat-
ing substances affect the mechanism of thrombus growth
on a microscopic scale. The effect of flow, aggregate size,
aggregate geometry, and number of aggregates on those
concentration profiles was also investigated. Finally,
while some effects of disturbed flow and vortices in
thrombogenesis have been measured experimentally by
others (16, 17), the size of the recirculating regions
developing on both sides of a thrombus, as well as the
magnitude of the embolizing stresses and the torque,
acting at the thrombus surface, were estimated in the
simulation, and their physiological relevance discussed.
MATERIALS AND METHODS
Collagen preparation
2.5 mg of type I acid-soluble human collagen (Sigma Chemical Co., St.
Louis, MO) purified by a pepsin extraction and salt fractionation
method from human placenta (18) were mixed with 1 ml of 0.012 N
HCI (pH 2) cooled at 40C in a polypropylene test tube. The test tube
was then placed on a low-speed nutator and the collagen allowed to
dissolve completely for one h at ambient temperature. This monomeric
collagen (tropocollagen) solution was kept at 40C until further utiliza-
tion. A neutralized, isotonic collagen solution was then prepared by
mixing 1 ml of chilled tropocollagen solution with 104.2 ,l of 0.1 M
NaOH and 104.2 Al of 10 X phosphate-buffered saline solution (0.2 M
Na2HPO4, 1.3 M NaCl, pH 7.4) to make a final collagen concentration
of 2.07 mg/ml. The pH of that solution was adjusted to 7.4 ± 0.2 by
addition of a few drops of 0.01 M HCI or 0.01 NaOH.
Flow chamber and collagen
coating
Heparin-anticoagulated whole blood with fluorescent-labelled platelets,
prepared as previously reported (19), was aspirated by a syringe pump
(Harvard Apparatus Co., Inc., South Natick, MA, Model 935) for two
and a half minutes at a controlled shear rate of 100 s-', 800 s-', or 1,500
s-1 from a test tube into a polycarbonate parallel-plate flow chamber,
described in detail elsewhere.20
The flow chamber, with a final slit width of 205 zm, served as a model
of a small blood vessel with a well-defined fluid-dynamical and rheologi-
cal environment, suitable for precise analysis of mural thrombogenesis.
Before being assembled as part of the flow chamber, 7.4 cm2 of a glass
cover slip (Corning Glass Works, Corning, NY; No. 1, 24 x 50 mm)
were coated with 71.5 LI of the neutralized tropocollagen solution (2.07
mg/ml), the remaining portion of the slide being covered with parafilm.
The slide was then placed in the bottom of a petri dish (Becton
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Dickinson Labware, Oxnard, CA; Falcon 1001, 100 x 15 mm) and
collagen fibrillogenesis initiated by allowing the dish to float for 12 min
in a water bath preheated at 370C. This technique, as reported by others
(21, 22), allows the monomeric collagen solution to polymerize into
native-type collagen fibrils of 67 nm periodicity, shown as the optimum
molecular configuration for platelet aggregation (22). The glass cover
slip was then placed under a ventilated hood and the collagen gel
supernatant allowed to evaporate completely for 30-60 min. The
collagen-coated glass was kept in a humid petri dish to prevent the
protein from denaturating until assembling of the flow chamber. By this
method, the glass cover slip is coated with a continuous layer of type I
(by classification) human collagen in fibrillar form, with an average
collagen density of -20 ,ug/cm2, which is within the range of densities
required for maximum platelet aggregation (23).
Video microscopy equipment
The parallel plate flow chamber, maintained at 370C by a thermostatic
air bath, was mounted on an inverted-stage microscope (DIAPHOT-
TMD, Nikon Inc., Garden City, NY) equipped with an epi-fluorescent
illumination attachment, a 100 x oil immersion objective, and a silicon
intensified target (SIT) camera (model C-1012, Hamamatsu Corp.,
Waltham, MA) suitable for very low light levels. The microscopy was
performed in EPI or incident-light mode due to the opacity of whole
blood. The experiments were recorded real-time on a half-inch color
video cassette recorder and the video tapes further analyzed by a digital
image processor (Perceptive Systems, Houston, TX; model 327). A
more detailed description of the video equipment is available elsewhere
(20).
Microscopic data analysis
Digital image processing was used to analyze the kinetics of thrombus
growth, to infer the three-dimensional structure of thrombi, and to
obtain different morphological information on each thrombus, including
basal area and average height at each shear rate. These data were then
used in the calculations of fluxes of platelet-activating substances in the
mathematical model (see Appendix C). The local visualization of mural
thrombogenesis was performed at the location of maximum macroscopic
platelet accumulation on the collagen-coated surface, as determined by
a microphotometric measurement system, described previously (19). At
the low wall shear rates of 100 s-' and 800 s-', maximum platelet
density occured near the beginning of the collagen coating because of
platelet diffusion-limited processes downstream. At the high wall shear
rate of 1,500 s-' the maximum occurred further downstream because of
embolization by fluid drag forces of the larger thrombi formed at the
inlet (24). Video tapes of experiments were digitized every 15 s and the
digitized images further processed and analyzed using various enhance-
ment and feature extraction routines. Image enhancement was per-
formed by a series of geometric and arithmetic operations, including
background subtraction, grey scale linear stretching, and spatial filter-
ing to eliminate the noise and increase object contrast in the original
digitized images. Different feature extraction routines were then applied
to the processed images to identify the platelets or the thrombi by
tracing their perimeters and performing computations on each object.
THEORY
Consider whole blood flowing at low Reynolds number
between the two parallel plates of a rectangular channel
200 gm-thick, over a two-dimensional model thrombus
attached to the bottom plate. The fluid approaches the
thrombus as a Newtonian fully-developed laminar flow
with a typical parabolic profile. A species of interest A is
released from the thrombus surface at a constant speci-
fied flux, NA. Some of the species analyzed will also react
by a first order bulk phase reaction, A -, B, where B is
some inactive form of A. The physical situation is
depicted in Fig. 1. The different cases treated in this
simulation, including the various object geometries and
sizes, as well as the situation where two aggregates,
located near or far away from each other, are growing on
the same surface, are shown in Fig. 2.
Chemical reactions
Thrombin is generated enzymatically on the surface of
the platelet, where factor Xa, activated by both the
intrinsic and extrinsic pathways, factor Va, and Ca2"
combine with platelet membrane phospholipids to form
the prothrombinase complex. This complex can rapidly
convert circulating prothrombin to thrombin (9). Because
this membrane reaction goes to completion immediately,
the rate of release of thrombin from the thrombus surface
was assumed equal to the rate of arrival of prothrombin to
the thrombus surface. Here we assumed that the amount
of thrombin produced from prothrombin diffusing inside
the thrombus is small compared with the amount pro-
duced on the thrombus surface. Thrombin released is
inactivated in the bulk phase by the circulating inhibitor
antithrombin III (AT III). This reaction is greatly accel-
erated in the presence of heparin, a commonly-used
antithrombotic agent (25). Mathematically, the reactions
;D
II,
io Ilmax ~ active Binactive
| / NA = constant
A
B
xIe 3
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FIGURE I Geometry of the parallel-plate flow chamber, used both for
the experiments and in the computer simulation. Blood flows from left to
right over a semicircular model thrombus of diameter L. A substance A
is released from the thrombus surface at a constant flux NA, and then,
may become inactivated by a first order chemical reaction in the bulk.
The fluid enters as a Newtonian fully developed laminar flow with a
typical parabolic profile.
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FIGURE 2 Model thrombus sizes and geometries. The six following
cases were analyzed: (i) rectangular model thrombus: (a) L = 10 Am,
DI = 4L, D2 = 1OL; (b) L = 20,um, D1 = 4L, D2 = 6L; (ii) semicircular
model thrombus: (a) L = 10 tAm, DI = 4L, D2 = 1OL; (b) L = 20,m,
DI = 4L, D2 = 6L; (Wii) two rectangular thrombi: L = 20 Am, D, = 1L,
D2 = 6L; (iv) two rectangular thrombi: L = 20 Am, DI = lL, D2 = 4L.
can be written as:
A B
B + C kt2 D
a rapid first order reaction at the
thrombus surface where A is assumed
to be completely consumed,
a second order bulk phase reaction
(the rate-limiting step) for which
k", the reaction rate constant, is
a strong function of heparin
concentration,
where A prothrombin; B thrombin; C AT III; D=
inactive complex.
Thromboxane A2, an arachidonic acid metabolite, has
a short half-life (43 s) in aqueous media and undergoes
rapid nonenzymatic hydrolysis to thromboxane B2, which
is inactive biologically (26). This reaction is as follows:
k"f
E F a rapid first order reaction,
where E = TxA2; F = TxB2.
Because ADP and vWF (ADP = G; vWF = H) have
relatively long half-lifes, compared with the time required
to activate platelets, they were assumed not to react in the
bulk phase. Indeed, although ADP is eventually metabo-
lized to AMP by the ADP-ases, studies have indicated
half-lifes of the order of 20-45 min for ADP in plasma
(27). Similarly, studies with plasma vWF have revealed
half-lifes of several hours for that protein (28). Disap-
pearance ofvWF by binding to platelet membrane glyco-
proteins was also not considered in this study.
Equations
The equations for the steady-state boundary-value prob-
lem describing the physical situation shown in Fig. 1 are
given in detail in Appendix A. In brief, the equation of
motion for an incompressible Newtonian fluid with con-
stant physical properties (the Navier-Stokes equation)
and the continuity equation were first solved for the
velocity field within the channel. That velocity field was
then used to solve the convection-diffusion equation for
the concentration profile of each platelet-activating agent
developing in the vicinity of a given model thrombus at a
specific wall shear rate. Those equations were solved
numerically using a finite element method, as explained
in depth in Appendix B.
Biodynamical properties
The sizes of the standing vortices developing upstream
and downstream of the model thrombi because of the
disturbed flow, were estimated by calculating the distri-
bution of the shear stress t,, the tangential component of
the stress vector, along the bottom plate and the thombus
surface. The i-component of the stress vector t is given
by:
t; = ffojnj; rjj = -P6cj + (V;J + Vj,i), (1)
where ajj is the stress tensor; nj is the unit normal vector at
the boundary; and 6jj is the Kronecker delta. Here the
comma represents partial differentiation with respect to
the following index, and repeated indices imply summa-
tion. The separation and reattachment points, as shown in
Fig. 3, are defined as the points where the shear stress
changes sign. The size of those recirculating regions was
also estimated graphically by plotting streamlines around
the object. For two-dimensional incompressible flow, the
stream function is the remaining non-zero component
of a vector potential which satisfies the continuity equa-
tion identically. Therefore, by definition:
a",
Vx= ; Vy=
ay Ox (2)
The forces acting on the thrombus surface, possibly
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and q1 represents the path along the object boundary. The
moment coefficient (CM), defined as the dimensionless
torque acting on the object, was also computed according
to:
f rtn sinodt + frtt sin0dq
C 7 =1
0.5 pU2h'
(4)
+Lu 0d
FIGURE 3 Definition sketch of the standing vortices developing around
a semicircular model thrombus. S, separation point; R, reattachment
point. The normal and tangential components of the stress vector, t, and
t,, are also shown.
leading to embolization of the aggregate, were estimated
as a function of Reynolds number (Re), model thrombus
geometry and size. By definition, the total force acting on
the object is the surface integral of all normal and
shearing stresses acting on it. The component of the
resultant force parallel to the undisturbed initial velocity
is called the drag D, while the component perpendicular
to that direction is called the lift L (29). The dimension-
less coefficients for lift (CL) and drag (CD) were calcu-
lated according to:
It. d7
CD = 0.5 pU2h
fty d?
CL= 1
0.5 pU2h
(3)
where U is the velocity of the undisturbed flow at the top
of the object; h is the object height; tx and ty are
respectively, the x and y components of the stress vector;
where r is the distance between the origin and the point of
action of the force; 0 is the angle between t, and r; and 0 is
the angle between t0 and r (see Fig. 3). It should be
pointed out that, for geometrically similar objects, those
dimensionless coefficients are functions of one parameter
only, the Reynolds number. In other words, for a given
thrombus geometry, the thrombus size is not a variable
(29).
The average basal shear stress (TS) and average basal
tensile or normal stress (n,) were also computed according
to:
TS = CD0.5 pU2h/L and Tn = CL0.5pU2h/L, (5)
where L represents the object diameter in the case of a
semicircular model thrombus, and the object length in the
case of a rectangular one.
Estimation of the model
parameters
The model parameters for the platelet-activating agents
and the chemical reactions, as well as the shear-rate
dependent physical parameters are summarized in Tables
I and 2, respectively. Those parameters were either
TABLE 1 Model parameters for the platelet-activating agents and the chemical reactions
Pseudo 1O order Initial whole
Chemical Molecular Brownian diffusion reaction rate Amount per blood
species weight coefficient, Db* constant, k platelet** concentrationtt
daltons cm2/s s-'
ADP 424.2 2.57 x 10-6 2.4 x 10-'7 mol 0.000
TxA2 352.5 2.14 x 10-6 0.0161t 0.95 x 10 20mol/s 0.000
Prothrombin 72000 3.32 x 10-7 0.869AM
Thrombin 36600 4.16 x 10-7 - 0.000
Antithrombin III 62000 3.49 x 10-7 0.0201w 2.844 LM
Heparin 16000 11.85011 127.0'
vWF 1.20 x 10-7 0.2 x 10-9 U 0.608 U/ml
*See references 15, 51.
tFor the nonenzymatic hydrolysis of TxA2 to TxB2 (see reference 15).
§For the inhibition of thrombin by 2.844,uM AT III alone.
I'For the inhibition of thrombin by 2.844 MM AT III accelerated by 2.0833 ,uM heparin (300 USP units/mg), the experimentally used
concentration.
'For the inhibition of thrombin by 2.844 AM AT III accelerated by 0.09 AM heparin, the concentration for maximum rate of inhibition.
**See references 51, 52.
~tAssuming an average hematocrit of 39.2%.
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TABLE 2 Shear rate dependent parameters
Wall Shear Apparent Enhanced Diffusion Reynolds number1
Rate Viscosity, ,* Coefficient, Dit (Re)
s-I cp cm2/s
100 4.223 1.36 x 10-6 0.178
800 3.405 1.09 x lo-, 1.770
1500 3.288 2.04 x I0-s 3.436
*See reference 55.
tCalculated from Eq. C3.
'Re = p Vmax B/li.
obtained from the literature or estimated as shown in
Appendix C.
The experimental data on thrombus growth rates and
sizes, as well as the estimated platelet-activating agent
wall fluxes are summarized, as a function of wall shear
rate and thrombus size, for the semicircular and rectan-
gular model thrombi, in Tables 3 and 4, respectively. The
details of those flux calculations are also shown in Appen-
dix C.
RESULTS AND DISCUSSION
The effects of viscous shear flow on the mechanics of
thrombus growth and embolization, as well as the concen-
tration profiles of four potential platelet-activating sub-
stances generated in the vicinity of various model throm-
bi, were estimated at various wall shear rates, spanning
the physiological range. The reasons for taking the effect
of wall shear rate into account and for choosing two
particular model thrombus geometries in this study, were
obtained from the following experimental observations. A
pseudo-color enhanced representation of three-
dimensional reconstructions of thrombi formed after 120
s of blood flow at 1,500 s-' over a human collagen-coated
surface is shown in Fig. 4. As can be observed from that
figure, the actual thrombi have steep edges, are irregu-
larly shaped on the top, and are elongated in the flow
direction. These thrombi could well be imagined as hav-
ing contours shaped between that of a perfect semicircle
and that of a perfect rectangle. Similarly, Fig. 5 shows
three-dimensional reconstructions of thrombi formed
after 120 s of flow at three different wall shear rates,
1,500 s-', 800 s-', and 100 s-'. This figure illustrates, in a
qualitative manner, the fact, observed by others (30), that
the rate of platelet accumulation on a thrombogenic
surface increases with increasing wall shear rate, result-
ing in thrombi of different sizes. Because the wall fluxes
of all platelet-activating agents depend primarily on the
rate of thrombus growth or the thrombus size itself, it was
therefore necessary to consider the effect of wall shear
rate when estimating those fluxes in this study.
Effects of viscous shear flow
Although the problems of a circular cylinder and a sphere
exposed to a uniform shear flow are well-known ones in
fluid mechanics (29, 31), the situation of a small object
attached to a plane wall in a uniform viscous shear flow
has been considered by relatively few investigators. (32-
34). Therefore, our objective was to study quantitatively
the effects of viscous shear flow on a growing thrombus as
a function of wall shear rate and model thrombus size and
geometry, and to discuss the implications of those effects
with respect to the thrombogenesis mechanism.
The schematic definition of the standing vortices devel-
oping upstream and downstream of a growing thrombus
as a result of viscous shear flow is given in Fig. 3. The
lengths L. and Ld of the upstream and downstream
vortices, respectively, as well as the reattachment angle
fR and the separation angle Os, are shown in Table 5 as a
function of the particle Reynolds number Rh and model
thrombus. In general, our results confirm the predictions
made by Kiya and Arie (32) and, also shown by Mills
(34) for creeping flow (Rh < 0.1) over a square-edged
orifice plate in a circular pipe, that standing vortices do
develop upstream and downstream of the obstacle even in
the limit Rh 0. This is in contrast to the case of a
circular cylinder or a sphere in a uniform shear flow, for
which a separated region with back-flow appears behind
the object when the Reynolds number approaches 3.5 for
TABLE 3 Model parameters for the circular model thrombi
Wall shear Thrombus Thrombus
Diameter rate Time growth rate size ADP flux TxA2flux Thrombin flux vWF flux
Am s-I s platelet/s platelets molt,4m2s x 1020 mol/IAm2s x 1021 UIAm2s x 109 U/Mm2s x 1012
100 83.68 2.27 44.9 34.7 2.71 0.90 2.9
10 800 12.17 3.55 28.2 54.3 1.71 6.80 4.5
1500 19.16 3.04 26.1 46.5 1.58 12.6 3.9
100 130.32 2.87 170.4 11.0 2.57 1.30 0.9
20 800 109.95 2.63 209.3 10.1 3.16 10.1 0.8
1500 55.500 6.76 209.4 25.8 3.17 18.8 2.2
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TABLE 4 Model parameters for the rectangular model thrombi
Wall shear Thrombus Thrombus
Length Height Width rate Time growth rate size ADP flux TxA2 flux Thrombin flux vWF flux
,mm m JAm s-I s platelet/s platelets molIjm2's x 102 MOl/jiM2S X 12J U/jIm2s x 109 U/1Um2s x 1012
100 89.07 2.41 57.5 23.2 2.18 0.90 1.9
10 5 7.5 800 15.48 3.28 39.5 31.5 1.50 7.10 2.6
1500 22.63 3.47 37.5 33.2 1.42 13.2 2.8
100 143.00 2.79 206.3 6.70 1.96 1.40 0.6
20 10 15 800 135.56 4.84 302.7 11.6 2.87 10.8 1.0
1500 68.030 7.66 300.0 18.4 2.85 20.0 1.5
the former (32) and 20 for the latter (29). The data
presented in Table 5 indicate that Lu and ,BR decrease
slightly with increasing Rh, while Ld and Os increase
slightly with increasing Rh, which is consistent with the
data presented in Figs. 7 and 8 by Kiya and Arie (32).
Whereas their data show that for large Rh the down-
stream vortex is always much larger than the upstream
one, our data reveal that both standing vortices become
geometrically similar as Rh - 0. The size of both
recirculation regions is strongly dependent upon the
model thrombus geometry, as indicated by the relatively
large standing vortices formed with rectangular model
thrombi compared to those formed with semicircular
ones. The most interesting result, however, appears in the
case of two rectangular thrombi growing near each other
and separated by a distance equal to one thrombus length
or 20 ,um. Indeed, as shown by the streamlines in Fig. 6 b
and the data in Table 5, a large standing vortex, 20 ,um
long and 8-9 ,um high, develops between the two thrombi
at all wall shear rates investigated. On the other hand,
this large vortex is not present when the thrombi are
separated by 10 times a thrombus length or 200 ,um (see
Table 5).
Another effect of viscous shear flow is the nonuniform
fluid velocity distribution across the channel, and in
particular, the considerably reduced velocities in and near
the recirculating regions. This effect is shown graphically
by the velocity vector plot of Fig. 6 a, where the direction
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FIGURE4 Estimation of the three-dimensional structures of thrombi formed after 120 s of blood flow at 1,500 s' over a type I human
collagen-coated glass cover slip in a parallel plate flow chamber. Flow is from left to right. The length bar applies to both the length and the height of
the thrombi. Light blue represents the bottom of the thrombi, whereas red represents the top.
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FIGURE 5 Effect of wall shear rate on the kinetics of thrombus growth. The same comments as those in Fig. 4 apply.
and the length of the arrow represent, respectively, the above the thrombi, are very small when compared to those
direction and magnitude of the velocity vectors, plotted at in the bulk. In fact, at 1,500 s-1, the smallest velocity
each nodal point. From that figure, one can see that the vector estimated has a magnitude of 0.0375 cm/s, while
velocity components in the recirculating wake regions and the speed of the entering fluid at the top of the objects, U,
their surroundings, as well as in the fluid layer directly is 1.425 cm/s. Similarly, at 100 s-, the smallest calcu-
TABLE 5 Sizes of the standing vortices as a function of Reynolds number and model thrombus
nA m*EBES
Semicircle Rectangle Semicircle Rectangle D = 20,m D = 200Mm
Rh L =lO,um L = lOMm Rh L = 2OAm L = 20,m A B A B
0.016 0.980 3.640 0.064 1.780 3.470 4.860 20.000 4.880 2.830
LU 0.008 0.990 3.670 0.033 1.820 3.500 4.870 20.000 4.890 2.940
0.001 1.060 3.760 0.003 1.920 3.600 4.880 20.000 4.900 3.260
0.016 1.020 4.470 0.064 1.950 3.630 20.000 7.830 3.200 7.900
Ld 0.008 1.010 4.450 0.033 1.910 3.570 20.000 7.750 3.120 7.720
0.001 0.990 4.410 0.003 1.850 3.490 20.000 7.610 3.060 5.960
0.016 4.900 35.700 0.064 4.120 34.900 28.410 41.700 28.620 36.500
OR 0.008 5.000 35.800 0.033 4.260 35.070 28.530 41.740 28.990 36.750
0.001 5.660 36.100 0.003 4.740 35.460 28.670 41.800 29.280 38.050
0.016 5.350 29.700 0.064 4.900 30.850 38.800 30.000 32.200 29.820
Os 0.008 5.210 29.670 0.033 4.630 30.720 38.760 29.890 32.640 29.670
0.001 4.900 29.600 0.003 4.320 30.470 38.800 29.760 32.420 29.720
Lu and Ld are given in Am, whereas OR and fAs are given in degrees. For comparison, the Reynolds number is defined as in reference 32, namely, Rh
Uhp/l, where U is the undisturbed velocity at the top of the object, and h is the height of the object.
*Two 20-Am-long rectangular model thrombi separated by a distance of 20,m.
tTwo 20-Am-long rectangular model thrombi separated by a distance of 200,um.
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FIGURE 6. Velocity vector plot (a) and streamlines (b) in the case of two nearby-growing rectangular model thrombi 20 gm long at Re = 0. 1 78. In a,
the direction and length of the arrows represent, respectively, the direction and magnitude of the velocity vectors, plotted at each nodal point. In b, the
values for the dimensionless stream function I* (where I* = '/ VmaxB) are: A = 0.16 x 10-4, B = 0.0, C = 0.10 x 10-3, D = 0.10 x 10-2, E = 0.50 x
10-2,F= 0.I0 x 10 ', G = 0.20 x 10-',H = 0.30 x 10-',I = 0.50 x 10-'.
lated speed in the vortex region is -2.5 x 10-3 cm/s,
while U is 95 x 10-' cm/s.
The drag coefficient CD, the lift coefficient CL, and the
moment coefficient CM, decrease more or less linearly
with the Reynolds number Rh, when plotted on a logarith-
mic scale, as shown in Fig. 7. Most noteworthy is that CD
and CM are always larger for the rectangular model
thrombus than for the semicircular one, whereas CL is
independent of thrombus geometry for Rh > 0.003. The
differences in CD values between the semicircular and the
rectangular protrusions are relatively small, however.
This was also reported by Basmadjian (35), who noticed
that CD values for small protrusions of different shapes
differed little over the full range of viscous flow. When
extrapolating the values of CD and CM obtained for the
semicircular projection to Rh= 0.1, our results agree
reasonably well with those obtained by Kiya and Arie
(32). Indeed, from the data of Fig. 7, CD and CM are 160
and 80, respectively, at Rh= 0.1, compared to 170 and
100 from Figs. 12 and 13 of Kiya and Arie (32). Also
shown in Fig. 7 is the case of two nearby-growing
thrombi. For that particular situation, CD and CM are
always larger for the upstream thrombus (A) than for the
downstream one (B), while the same values are found for
CL.
The average stresses and the torque acting on the
aggregate as it grows under the effects of viscous shear
flow, eventually leading to its embolization from the wall
surface, are summarized in Table 6, as a function of wall
shear rate and model thrombus. Both shear stress and
normal stress, as well as the torque, increase with increas-
ing wall shear rate, as normally expected. On the other
hand, the embolizing stresses are insensitive to thrombus
dimension. This was also shown empirically by Basmad-
jian (35), who found that in both creeping flow regime
(Rh < 0.1) and for sufficiently small protrusions (h/
2B < 0.05), shear stress and tensile stress are independent
of object height. Our numerical results for the average
shear stress rS agree within 25-30% with the values
predicted by a semi-empirical equation derived by Bas-
madjian (35) (-s = 30,u (V) 2/2B, where ( V) equals
2/3 Vmax and represents the average fluid velocity across the
channel). Also shown in Table 6 is the slightly larger
average shear stress acting on the rectangular object
compared to the one acting on the semicircular object,
whereas the average normal stresses are similar for both
geometries. In the case of two nearby-growing thrombi,
the average shear stress and the torque acting on the
downstream thrombus (B) are reduced by -25% when
compared with those acting on the upstream one (A),
which could favor the growth of the former aggregate.
Again, the average normal stresses are similar for both
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FIGURE 7 Drag coefficient CD, lift coefficient CL, and moment coeffi-
cient CM as a function of the Reynolds number Rh, defined in terms of
the undisturbed velocity at the top of the object U and the height of the
object h as Rh = Uhp/l. Solid lines are used for single rectangular or
semicircular model thrombi, whereas dashed lines are used for two
nearby-growing rectangular model thrombi.
thrombi. It is interesting to notice that at the low wall
shear rate of 100 s-' both shear stress and normal stress
have relatively similar values, while, as the wall shear rate
increases, the shear stress becomes the predominant
embolizing stress. As distinct from the stresses, the torque
is not only a function of thrombus geometry but also a
function of thrombus size.
Fig. 8 shows four pseudo-color enhanced images of
growing thrombi, digitized after, respectively, 30, 75,
105, and 120 s of blood flow over a collagen-coated
surface. This photograph explicitly shows that the large
zones of recirculation and back-flow (indicated by blue
crosses) developing between nearby-growing thrombi at
particular stages in the thrombosis process are also the
sites of massive platelet aggregation at later stages. The
region of recirculation present near the center of Fig. 8 A,
for instance, is completely covered with platelets 45 s
later, as indicated at the same location in Fig. 8 B.
Concentration profiles of
platelet-activating agents
The concentration profiles of released platelet-activating
agents are presented as three-dimensional plots in this
paper (see Fig. 10 for example), and those require a few
comments. The x-y plane in those figures represent the
actual channel geometry as drawn in Fig. 1, while the
concentration variation of the substance of interest over
that two-dimensional space is represented by the third
dimension (c axis). Blood is flowing in the positive
x-direction, that is, from right to left. All those figures
also exhibit two local maxima (labeled 1 and 2), and one
local minimum, upstream and downstream from the
thrombus and near the top of the thrombus, respectively.
The presence of local maxima is related to the standing
vortices which develop on both sides of the aggregate, as
mentioned earlier. Indeed, because those recirculating
regions are areas of low fluid velocities, the retention time
of any released material, and thereby its concentration, is
correspondingly larger in those regions. Although the
fluid velocities near the top of the aggregate are consider-
ably smaller than those in the bulk, as shown previously,
they are, however, larger than those within the vortices,
which explains the presence of a local minimum in that
region. In fact, as one moves away from the wall or the
aggregate surface into the bulk, the convective dispersion
rapidly becomes important, resulting in steep decreasing
concentration gradients. Therefore, only platelets that
flow in close proximity to the thrombus surface or the wall
surface have a chance to become activated, and subse-
quently to aggregate, either by being trapped in the vortex
regions or by flowing directly within the zone of high
concentration of platelet-activating agents present near
the top of the thrombus. It should be pointed out that the
downstream maximum is always larger than the
upstream one, which can be explained as follows: some of
the molecules released from the upstream part or the top
of the thrombus are carried along by convection in the
direction of the downstream vortex, increasing the local
concentration there. This theoretical result correlates well
with previous experimental observations made in our
laboratory (19, 24, 36). Indeed, it was postulated that
"fresh" platelets arriving at the site of aggregation
become activated as they pass through a "cloud" of
platelet-activating agents surrounding the thrombus, and
therefore adhere preferentially at the downstream edge of
the aggregate. In addition, as will be shown below, the
concentrations of platelet-activating agents accumulating
in the vortices present between nearby growing thrombi,
are significantly larger than those found in the vicinity of
isolated thrombi. This result may also explain the experi-
mental observation mentioned earlier in this report, that
platelets aggregate massively in the spaces between adja-
cent thrombi.
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TABLE 6 Average shear and normal stresses, and the torque, as a function of wall shear rate and model thrombus
[m
Wall shear Semicircle Semicircle Rectangle Rectangle D = 20, m
Stress* rate L = lOlAm L = 2O0m L = 10tm L = 20,um A B
s-I
Shear stress 100 15.0 15.5 20.0 19.5 21.0 16.5
'r. 800 95.0 94.5 117.0 118.5 137.0 99.0
1500 171.0 170.5 213.0 214.5 250.5 177.5
Normal stress 100 25.5 20.0 20.0 20.0 20.5 21.0
800 43.0 49.5 43.0 49.0 55.0 56.0
1500 65.0 74.5 71.0 73.0 86.5 86.0
Torque 100 0.003 0.017 0.009 0.033 0.035 0.028
x i03 800 0.027 0.106 0.051 0.204 0.228 0.168
1500 0.049 0.192 0.092 0.412 0.417 0.302
*AIl stresses are given in dynes per square centimeter and the torque in dynes-centimeter.
ADP
Shown in Fig. 9 is the maximum ADP concentration (in
micromolar) as a function of wall shear rate and model
thrombus. As can be seen from that figure, the maximum
ADP concentration increases with decreasing wall shear
rate. This can also be visualized by comparing the three-
dimensional plots of Figs. 10 and 11 for the 10 ,um-long
semicircular model thrombus at 100 s- and 1,500 s-1,
respectively. The curves in the upper left-hand corners of
those figures represent the variation of the ADP concen-
tration at the wall as a function of axial position in the
channel. The points labelled 1 and 2 correspond to the two
maxima on the 3-D plots, and are located, respectively, at
the upstream and downstream intersections between the
bottom plate of the channel and the model thrombus. At
100 s- Ithe larger maximum has a value slightly above 4.5
,uM, while at 1,500 s-' it is only -0.75 ,uM, which
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FIGURE 8 Pseudocolor enhanced images of mural thrombi digitized after 30 s (A), 75 s (B), 105 s (C), and 120 s (D) of blood flow over a
collagen-coated surface at 1,000 s- . The fluorescence intensity ranging from black to white in the original monochrome video image is mapped into a
transition from blue to red, where blue represents the surface background and red the regions of intense platelet accumulation. The blue crosses, in
that figure. indicate the location of possible standing vortices developing between growing thrombi.
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FIGURE 9 Maximum ADP concentration as a function of wall shear
rate and model thrombus. Solid lines are used for single thrombi,
whereas dashed lines for two thrombi. A similar notation to the one of
Fig. 2 is used for designating the different model thrombi: (i) rectangu-
lar model thrombus, (a) L = 20,um, (b) L= 10 Am; (ii) semicircular
model thrombus, (a) L = 20 Arm, (b) L= 10 ,um; (iii) two rectangular
model thrombi, L = 20 ,um, D = 20 Mrm; (iv) two rectangular model
thrombi, L = 20 ,um, D = 200 tm. L represents the thrombus length or
diameter, and D the distance separating the thrombi.
FIGURE 1O ADP concentration prodile over a semicircular model
thrombus 10lm in diameter. Whole blood flows from right to left at a
wall shear rate of 100 s-1. The x-y plane represents the actual channel
geometry with the wall at y = 0, whereas the height at any nodal point in
the x-y plane corresponds to the magnitude of the ADP concentration at
that point.
FIGURE ii ADP concentration profile over a semicircular model
thrombus 10,m in diameter. Whole blood flows from right to left at a
wall shear rate of 1,500 s-'. The same comments as those of Fig. 10
apply.
corresponds approximately to a decrease of 83% due to
the increase in wall shear rate. This decrease in ADP
concentration with increasing shear rate is due to both
larger convective and diffusive forces at the high shear
rate, which tend to reduce the residence time of ADP
molecules around the aggregate despite the increase in
flux (see Tables 3 and 4). Our results are considerably
larger than those found in the case of a flat model
thrombus (15). Indeed, values of 0.7 AuM and 0.32 ,aM
were reported for flow over a flat 1 0-,um-long thrombus at
100 s- and 1,500 s-', respectively. These differences are
due first to the presence of large vortices in our simulation
and second, to the fact that ADP fluxes were underesti-
mated in the previous analysis.
Whereas thrombus size or geometry does not seem to
affect, to any significant extent, the maximum ADP
concentration at high wall shear rates, it certainly does at
low wall shear rates, as shown in Fig. 9. In general, the
maximum ADP concentration is larger for a semicircular
model thrombus than for a rectangular one, and it
decreases with increasing size. At 100 s-', for instance,
the maximum ADP concentration for the 10 ,um-long
semicircular model thrombus is slightly above 4.5 ,uM, as
mentioned earlier, while it is only around 2.5 ,uM for the
20-,um-long one. It should be stressed, however, that this
value is still somewhat larger than the 0.90 ,tM reported
for a 20-,um-long flat thrombus (1 5). The reason for that
decrease is that the ADP flux from the aggregate surface
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depends upon the rate of platelet arrival to that surface.
Although the rate of platelet arrival, as determined
experimentally, is greater for rectangular model thrombi
than for semicircular ones, and increases slightly with
increasing thrombus size, the rate of arrival per unit area
is smaller for large thrombi and/or rectangular ones
because of their larger surface area, especially at low
shear rates (see Tables 3 and 4).
As shown in Fig. 12 B, the region of recirculation and
back-flow developing between two nearby-growing 20-
,um-long rectangular thrombi is also a zone of local high
ADP concentration. This is not present, however, in the
case of two similar thrombi separated by ten times the
same distance, as shown in Fig. 12 A. In fact, at 100 s-',
the maximum ADP concentration increases by 22%,
when compared to the case of a single growing thrombus
or of two distant thrombi of the same size. As shown
quantitatively in Fig. 9, this effect increases with decreas-
ing wall shear rate.
As reported by others (37), the level of ADP required
to cause platelet shape change and irreversible aggrega-
tion in platelet-rich-plasma (PRP) is 0.2 ,uM and 1.0 M,
respectively. Our results lie in the region of the minimum
threshold for irreversible platelet aggregation. It is likely,
however, that as the wall shear rate and thrombus size
increase, the maximum ADP concentration could
decrease below that minimum. In other words, ADP is
likely to play its most important role in the thrombogene-
sis process at low shear rates, typical of the venous system,
and during the early stages of the process, when aggregate
sizes are relatively small.
TxA2
The variation of the maximum TxA2 concentration (in
nmolar) with wall shear rate is shown in Fig. 13 for
different model thrombi. As for ADP, the maximum
TxA2 concentration increases with decreasing wall shear
rate. This is also shown qualitatively in Fig. 14 for the
20-,um-long rectangular model thrombus, for which the
maximum TxA2 concentration passes from 12.9 nM at
1,500 s-', to 20.9 nM at 800 s-1, and to 61.2 nM at 100
s-', corresponding to a total increase of 79%. The maxi-
mum TxA2 concentration increases with increasing
thrombus size, and does not vary much with thrombus
geometry (see Fig. 13). The former observation is basi-
cally due to the fact that the TxA2 flux from the thrombus
surface depends on the total number of platelets constitut-
ing that thrombus, and not on the rate of platelet arrival
to the thrombus, as is the case for ADP. The latter
observation is a result of the relatively similar fluxes
estimated for the rectangular and semicircular model
thrombi, as shown in Tables 3 and 4. Also shown in Fig.
13 is the significant increase in maximum TxA2 concen-
tration in the case of two nearby-growing thrombi when
compared to the case of a single thrombus or of two
distant thrombi of the same size, especially at low shear
rate. At 100 s-', for instance, that increase is -21.2%.
In general, our values for the maximum TxA2 concen-
trations are smaller than those reported earlier for the
flow over a flat thrombus (15). For example, the maxi-
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FIGURE 13 Maximum TxA2 concentration as a function of wall shear
rate and model thrombus. The notation is similar to the one used in
Fig. 9.
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FIGURE 12 ADP concentration profile over (a) two 20-gm-long rectan-
gular model thrombi 200 ,um apart, (b) two 20-tim-long rectangular
model thrombi 20 ,m apart. Whole blood flows from right to left at a
wall shear rate of 100 s-'.
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FIGURE 14 Effect of wall shear rate on TxA2 concentration profile over
a 20-am-long rectangular model thrombus: (a) 1,500 s-'; (b) 800 s-';
(c) 100 s'.
mum value found in the case of a 20-,um-long semicircular
model thrombus at 100 s-5 is slightly above 60 nM,
whereas the same value was reported to be -200 ,uM in
the case of a flat thrombus. This apparent discrepancy is
mostly due to overestimation of the TxA2 fluxes, espe-
cially for the large aggregates, reported in the case of a
flat thrombus.
Because TxA2 has a short half-life in aqueous solution,
it is difficult to determine what TxA2 concentrations are
needed to stimulate platelet activity in vitro. Therefore, it
(C) A
is assumed, as mentioned by others (15), that the biologi-
cal behavior of TxA2 is similar to the one of its close
analogue, U-466 19 (11 ,9-epoxy-methano analogue of
PGH2, Upjohn Company), which causes shape change at
concentrations of 6-60 nM, reversible aggregation at
110-300 nM, and irreversible aggregation at concentra-
tions >600 nM (38). According to those numbers, the
concentrations calculated for TxA2 are only sufficient to
cause platelet shape change. It is possible that, as the
thrombus grows larger, enough TxA2 will be released to
cause reversible platelet aggregation. On the other hand,
it is very unlikely that TxA2 alone could induce irrevers-
ible platelet aggregation. Those results confirm the exper-
imental data reported by Baumgartner (39) who showed
that preventing TxA2 generation by blocking cyclooxy-
genase activity with aspirin caused little change in throm-
bus formation in heparin anticoagulated or native rabbit
blood on subendothelium.
Thrombin
The maximum thrombin concentration is presented in
Table 7 as a function of wall shear rate, heparin concen-
tration, and model thrombus geometry. Thrombin is
known to cause irreversible platelet aggregation at levels
of 0.1-0.3 units/ml in PRP (37). All the values shown in
Table 7 are significantly larger than the minimum thresh-
old required for irreversible platelet aggregation. Indeed,
the calculated maximum thrombin concentration values
range from 279.2 to 21.8 U/ml, both found in the case of
two nearby-growing thrombi, respectively, at 1,500 s-'
with no heparin and at 100 s-' with 0.09 ,uM heparin (see
Table 7).
The maximum thrombin concentration drops very
drastically when thrombin is inhibited by AT III in
TABLE 7 Maximum thrombin concentration as a function of wall shear rate, heparin concentration,
and model thrombus
Wall shear Heparin Semicircle Semicircle Rectangle Rectangle IA MI .ALJID
rate concentration L- 1OAm L 20um L= lO,um L-20um D= 20Mm D - 200jum
s-' 'UM
0.0000 178.0 210.3 192.7 230.3 279.2 252.6
1500 2.0833* 170.7 194.3 181.6 201.9 225.6 222.0
0.0900$ 124.1 115.5 119.7 87.8 155.4 144.5
0.0000 176.4 208.0 190.9 227.3 276.5 249.5
800 2.0833 163.5 180.6 171.6 181.1 194.3 199.4
0.0900 95.3 102.6 114.1 86.1 72.0 81.4
0.0000 144.8 140.1 156.3 184.1 224.9 202.3
100 2.0833 96.5 92.6 92.3 70.0 72.8 83.3
0.0900 30.0 26.8 57.4 22.7 21.8 49.2
*The experimentally used heparin concentration.
tThe heparin concentration for maximum rate of inhibition (see reference 25).
A1l thrombin concentrations are given in units per milliliter.
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presence of heparin. This is shown both quantitatively in
Table 7 and qualitatively in Fig. 15 for the 20-,m-long
rectangular model thrombus at 800 s- . In that figure, the
maximum thrombin concentration drops from 227.3 U/
ml in absence of heparin, as would be found in an
unaltered physiological environment (Fig. 15 C), to 86.1
units/ml in presence of 0.09 uM heparin, the concentra-
tion at which the enzymatic inactivation of the released
thrombin by AT III is maximum (Fig. 15 A) (25). An
intermediate value of 181.1 U/ml is found in presence of
2.0833 ,M heparin, the experimentally used concentra-
tion (Fig. 15 B) (19). Most noteworthy in Fig. 15 A is the
lack of a concentration tail downstream of the aggregate,
as well as the small peaks on both sides of the thrombus,
when compared to Fig. 15 C. Those results are a conse-
quence of the rapid inactivation of thrombin molecules, as
they are released from the aggregate, by the circulating
AT III molecules when heparin is present. In fact, the AT
III molecules present in the standing vortices keep large
quantities of thrombin molecules from accumulating in
those regions, thereby reducing considerably the size of
the two concentration maxima. Furthermore, because of
this rapid inactivation reaction, thrombin molecules have
no chance to diffuse away from the wall or to be carried
by convection downstream from the aggregate. At 3 ,m
from the wall, for instance, the maximum thrombin
FIGURE 15 Effect of heparin on thrombin inhibition by circulating AT
III. The thrombin concentration profiles are shown over a 20-,um-long
rectangular model thrombus at 800 s-'. The heparin concentrations in
whole blood are as following: (a) 0.09 ,M heparin, the concentration for
maximum rate of inhibition, (b) 2.0833 AM heparin, the experimental-
ly-used concentration, and (c) no heparin.
concentration drops to 0.051 and 0.018 U/ml in Figs. 15,
C and A, respectively, which correspond to a 4,457- and
4,783-fold decrease when compared to the maximum
values at the wall.
The effect of wall shear rate on the maximum thrombin
concentration is also shown in Table 7. In general, that
value decreases with decreasing shear rate, and this effect
is particularly noticeable when the rate of thrombin
inhibition is accelerated by heparin. For instance, in the
case of a 20-,um-long rectangular model thrombus, the
maximum thrombin concentration decreases by 20.1%
when the wall shear rate decreases from 1,500 s- to 100
s- with no heparin present, while that decrease is 74.1%
with 0.09 AM heparin. This result can be explained by the
fact that the rate of thrombin production increases while
its rate of inhibition decreases, with increasing wall shear
rate. Indeed, at low wall shear rates, the convective forces
near the thrombus surface are relatively small, and the
potential residence time of the released thrombin mole-
cules comparatively long. In those conditions, AT III
molecules become more effective in inhibiting a large
number of thrombin molecules, particularly when the rate
of reaction is enhanced by heparin. In addition, the rate of
thrombin production increases with increasing wall shear
rate because of the increasing diffusive and convective
forces carrying prothrombin, the precursor of thrombin,
from the bulk to the aggregate surface. This is also shown
in Tables 3 and 4 as an increase in thrombin flux with wall
shear rate.
Our calculated thrombin concentration values are con-
siderably larger than the values reported for planar
thrombi, mainly because the estimated thrombin fluxes
were underestimated in the previous analysis (15). In
addition, contrary to those previously reported data, our
results predict a decrease in thrombin concentration with
increasing thrombus size and decreasing wall shear rate,
in presence of heparin.
It is clear from our results that thrombin is likely to be
the most potent platelet-activating substance, and there-
fore, should play a profound role in the mechanism of
mural thrombogenesis on collagen, even in the presence of
heparin. These findings agree well with the very recent
data reported by other groups (40-42), which indicate
that thrombus formation in vivo on damaged blood vessels
is a thrombin-mediated, but heparin-resistant, process.
Platelet-released vWF
The maximum vWF multimer concentrations developing
in the vicinity of various model thrombi are shown in Fig.
16 at two extreme wall shear rates, 100 s-l and 1,500 s- .
For the same reasons as mentioned earlier for ADP, the
maximum vWF concentration values increase with
decreasing shear rate and thrombus size, are larger for
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FIGURE 16 Maximum platelet-released vWF multimer concentration
as a function of wall shear rate and model thrombus. The notation is
similar to the one used in Fig. 9.
semicircular model thrombi than for rectangular ones,
and increase in the case of two nearby-growing thrombi,
when compared to the case of a single thrombus or of two
distant thrombi of the same size. At 100 s-', for instance,
that increase is -25.0%.
The endogenous human platelet vWF multimers
include unusually large vWF multimeric forms similar to
those released by endothelial cells (ECs) and larger than
the largest multimeric forms found in normal human
plasma (43). Moake et al. showed that both vWF multi-
mers secreted by ECs and those released by platelets are
more effective in inducing shear-induced platelet aggre-
gation than the largest plasma forms (43, 44). Also, the
antigenic levels of those ultralarge vWF multimers
required to cause platelet aggregation are considerably
smaller than vWF antigen levels found in normal human
plasma (I unit/ml) (43, 44). In fact, they showed that
antigenic levels of platelet-released vWF < 0.015 units/
ml can cause massive platelet aggregation at relatively
high shear stress (120 dynes/cm2), in the presence of a
small amount of ADP serving as a cofactor (43). The
same group showed that 0.05 units/ml of EC-secreted
vWF multimers is sufficient to cause massive platelet
aggregation when platelets are sheared at 180 dynes/cm2
(44).
With those numbers in mind, the data of Fig. 16 clearly
indicate that platelet-released vWF multimers may be
important in platelet/platelet adhesion in flowing systems
and/or in thrombus consolidation due to bound vWF
multimers on adjacent platelet membranes, especially at
low and intermediate wall shear rates (<1,000 s-I). This
finding is particulary important because, while the role of
vWF in inducing platelet-vessel wall and platelet/platelet
interaction has been reported as essential mostly at high
shear rates (23, 45), these results and the recently
reported experimental data by Badimon et al. (46) indi-
cate that vWF may also modulate those effects at low wall
shear rates.
CONCLUSIONS
When interpreting our data in the context of thrombus
formation, it should be remembered that platelet-activat-
ing substances are known to act synergistically with each
other. Therefore, subthreshold concentrations of one
agent present with subthreshold concentrations of
another agent may cause platelet activation. It has been
found, for instance, that nanomolar quantities of ADP are
sufficient to cause massive platelet aggregation, when
combined with large or unusually large vWF multimers
from plasma, platelets, or ECs (43).
Even in the presence of the anticoagulant heparin,
thrombin appears to be the most important of the platelet-
activating substances analyzed in this paper. The roles
played by ADP and platelet-released vWF may be signifi-
cant, especially at low shear rates and during the early
stages of thrombus growth. The role of TxA2 appears to
be secondary, but for the reasons mentioned above, this
low concentration of compound could stimulate platelets
to respond with greater sensitivity to other activating
agents. Furthermore, our results suggest that TxA2 may
become more important in the later stages of the throm-
bogenesis process, when the aggregates become larger
and the concentrations of other agents such as ADP or
thrombin diminish.
Standing vortices developing on both sides of individual
thrombi and between nearby-growing thrombi are
responsible for the observed rises in concentrations of
platelet-activating agents within those regions, and give
theoretical support to the experimentally-observed mech-
anisms of thrombus growth. Indeed, it has been reported
that thrombi grow primarily from their downstream
edges, and that massive platelet aggregation occurs in the
spaces between nearby-growing thrombi. In other words,
platelets accumulate preferentially in the regions of large
platelet-activating agent concentrations and low fluid
velocities. Finally, we observed that the average shear and
tensile stresses, acting on the thrombi, increase with
increasing blood flow rate, but are independent of throm-
bus size and only weakly dependent on thrombus geome-
try. In other words, embolization of such small protru-
sions may occur only at relatively high wall shear rate. In
fact, this correlates well with the previous experimental
observations from our laboratory (19, 24), that occasional
embolization of the larger thrombi (10-20 ,um high)
formed on collagen-coated glass occurred at wall shear
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rates >1,500 s-'. It is likely, however, that as the size of
the aggregate increases, the embolizing stresses may
become functions of both the wall shear rate and the
thrombus size. In this context, it is probable that emboli
forming in high flow rate vessels such as the arterioles, are
much smaller than those developing in the venous system
for instance. The latter ones, because of their large sizes,
could be potentially more dangerous for they are prone to
occlude small blood vessels distally.
with the following boundary conditions:
(a) upstream (x = xo):
Vy = 0; V,% = Vma [I - (B) ](parabolic profile) (A7)
(b) along top and bottom plate (y = ± B) and on the thrombus surface:
(A8)V% = Vy = 0 (no slip)
(c) downstream (x = xe):
in = tt = 0, (A9)
APPENDIX A
The convection-diffusion equation describing the physical situation
shown in Fig. I is given by
oc. oc. [O~,2C O2C.]V J+V -~
-j-kCr, (ld9 dy dJ,C X 2 2 (AJ)
where V% and Vy represent the x and y components of the velocity vector;
Cj is the concentration of the species of interest j; Dj,, is the effective
diffusion coefficient of species j in whole blood; k is a bulk phase reaction
rate constant; and C, is the product of the reactant concentrations. For
species E, Cr = Ce, while for species B, C, = Cb x C, where the
subscripts refer to the species as defined in the Theory section.
Eq. Al was solved with the following imposed boundary conditions:
(a) on the thrombus surface:
where V, are Vy are respectively, the x and y components of the velocity
vector V; V, , is the maximum velocity at the center of the channel; P is
the pressure; g is the gravity field; p and g are, respectively, the fluid
density and viscosity; t, and tt are the normal and tangential components
of the stress vector t; and V is the Laplace operator. At the outflow
boundary (x = x,) the assumption of fully developed flow is made; the
velocities are left free so that the boundary condition of zero stress in the
normal and tangential directions is obtained.
Eq. A I-A9 were then dedimensionalized by introducing the following
dimensionless quantities:
C* CjDj.e P= N* - LNjB pV2 PeNjf B
kB gB V
k*~m a%2 V*=
vmax nmax vmax
Ca= O; Db.e aCb = -Da8C a ; Djc aaCi = NjO3n an a
forj = e,g,orh (A2)
(b) upstream from the thrombus (x xo) and on the top plate (y - B)
Cj=Cj, forj=a,c,h; C,=0 fori=b,e,g (A3)
(c) downstream from the thrombus (x = xj)
.C2= 0 vj(
where n is the direction normal to the boundary. For a given wall shear
rate, the flux Nj is constant for ADP, TxA2, and vWF, and was
calculated from experimental data, as explained in Appendix C. The
flux of thrombin was estimated by first solving Eq. Al for prothrombin,
assuming a concentration of prothrombin equal to zero at the thrombus
surface and then calculating the flux of prothrombin over the surface
area of the object. That value, corrected for the difference in effective
diffusion coefficients between the two compounds, was used as the
thrombin flux. Cjo represents the initial concentration of substance j in
whole blood (see Table l).
To solve Eq. Al, the equation of motion for an incompressible
Newtonian fluid with constant physical properties (the Navier-Stokes
equation), together with the continuity equation, had to be solved for the
velocity field. Those equations, in vector notation, assuming steady
state, are given by
V- V=0
pV VV = -VP + /V2V + pg
L represents any length x, y, or n.
This yields, dropping the asterisks, the following system of weakly
coupled partial differential equations (PDEs):
V * v=0 (AIO)
V vV -VP + (ReV)2V + g
V. VCj (Pe) ) kC,
with the following dimensionless boundary conditions:
(a) on the thrombus surface:
aCb OC OC.
-.==a0 I 1.0Oan On' Oln
(All)
(A 1 2)
(A13)
for j = e, g, or h
V1 = Vy = 0 (A14)
(b) atx = xoandy = B:
Cj =O forj = b, e, org; Ci = N'B4
N,B
(A15)
for i = a, c, or h
(c) at x = x.:
(A5)
Oc.
=0 Vj; tn = tt = 0
Ox(A6) (A16)
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(d) at x = xo:
Vy=O; V.= 1-y2 (A17)
(e) aty = ±B:
V v=0. (A18)
The dimensionless parameter Re is the Reynolds number (pV, BIM)
which represents the ratio of inertial forces to viscous forces, and Pe is
the Peclet number (V,.,.x B/Di,.) which is the ratio of mass transport by
convection to mass transport by diffusion (47).
APPENDIX B
The system of weakly coupled PDEs and their boundary conditions,
given by Eqs. A IO-A 18, was solved by a finite element routine for fluid
flow, FIDAP (Fluid Dynamics International, Inc., Evanston, IL). A
preprocessor, with automatic mesh refinement capability, was utilized
to discretize the flow domain into a large number of elements. For a
typical rectangular model thrombus 20 ,um long, with the dimensions of
the flow domain shown in Figs. 1 and 2, we used 361 isoparametric
quadrilateral elements, each containing nine nodes, yielding a total of
1,549 nodal points. The Galerkin form of the Method of Weighted
Residuals was the minimization technique chosen in our simulation. The
velocity and concentration were approximated by a series of identical
biquadratic interpolation functions, whereas discontinuous linear
approximation functions were used for the pressure. The finite element
method (FEM) was applied to a perturbed system of equations in which
the continuity requirement, Eq. A 10, was replaced by
V -V == -,CP, (Bi)
where E, the penalty parameter, was chosen as 10-6. This approach has
the advantage of eliminating the dependent variable P from the
momentum equation without losing any significant accuracy, providede
is small enough (48).
The application of the FEM to the momentum and convection-
diffusion equations resulted in a set of nonlinear algebraic equations,
represented in matrix (bold face) form as
L(U)U = F, (B2)
where L is the global system matrix, U is the global vector of unknowns
(velocities and concentrations), and F is a vector which includes the
effect of body forces and boundary conditions.
A combination of two different iterative algorithms were used to solve
this sytem. First, the successive substitution (SS), or Picard iteration,
scheme, given below, was applied:
L(Ui)Ui+ = F. (B3)
The Stokes solution for the velocity field and a null concentration vector
served as the initial iterate U0. The advantages of this method are its
large radius of convergence and its insensitivity with respect to U0.
Because of its slow convergence rate, however, this technique was
replaced, after three iterations, by the faster quasi-Newton (Broyden's
update) (49) method of iteration, written as:
Uj= U- 0.8 Di; Di = SiRi (B4)
Si+ = Si + AS, (B5)
AS,- (XI+,-sir1+,)1T+, (B6)
i+l is +l
where X, = Ui - Ui,; r1 = R, - Ri-1; Ri is the residual force vector
R(Uj) = L(Ui)Ui - F; and S is the inverse of the Jacobian matrix of the
system of equations J-'(Ui) = (aRi/dOUi)-'. The initial Sowas calculated
from J-'(Uo) = (0Ro/0Uo)-', where U0 is the solution vector of the last
iteration by the SS method. This technique is more economical than the
Newton-Raphson method, for instance, because it only updates Si at
every iteration instead of recomputing it.
Iteration for the steady-state solution was terminated when the
following two convergence criteria were satisfied simultaneously:
IIlJi
-I~II
=0 1IlRi Ri11 i_l 0.01
11Rj1 s0 01,
(B7)
(B8)
where the norm 11 e 11 is a root mean square norm summed over all nodes
in the mesh.
The method adopted for solving the assembled matrix equation at
each iteration step was the direct Gauss elimination with a skyline
out-of-core storage mode initially developed by Hasbani and Engelman
(50). Finally, a postprocessor was used to output the various solution
variables in graphical form.
APPENDIX C
Flux
The wall fluxes of all platelet-activating substances, with the exception
of thrombin, were estimated, as a function of wall shear rate, from a
knowledge of their generation rates or amounts per platelet, and the
growth rates or sizes of the model thrombi. Although values for those
generation rates or amounts per platelet were obtained from other
sources (51, 52) (see Table 1), the number of platelets constituting an
average single thrombus at discrete times was measured in our labora-
tory at different wall shear rates by a technique previously reported
(20). Next, by assuming an average platelet volume of 10 Mm3, the
average thrombus volume was also estimated. Both data sets were then
curve-fitted with cubic polynomials using a least squares regression
technique. The experimental data and the curves fitting those data are
shown in Fig. 17.
The strategy used was to match the model thrombus volume to the
measured average thrombus volume, and solve the resulting cubic
polynomial for a feasible time root (0 < t [seconds] < 150). The number
of platelets per thrombus or the thrombus growth rate could then be
estimated, at that specific time, from the polynomials (or their time
derivatives) curve-fitting the data of Fig. 17. The details of the flux
computations are shown below for the 20-MAm-long hemispherical throm-
bus at 1,500 s-'. Because the calculations for ADP and vWF are similar,
only those for ADP are considered here.
ADP flux
80% of the ADP content of the dense granules in each platelet is
assumed to be instantaneously released as the platelet attaches to the
growing thrombus (51). The ADP flux is, therefore, essentially depen-
dent upon the thrombus growth rate. From reference 51, a single platelet
contains 3.0 x 1O- " moles ofADP inside its dense granules. The growth
rate of the model thrombus is estimated from the experimental data as
follows. The volume of a hemisphere, with a diameter of 20 ,um, is
(2/3)(r)(10)3 or 2,094.4 Am3. The polynomial curve-fitting the data of
Fig. 17 at 1,500 s-' is then set equal to that value:
2,094.40 -76.20 + 4.00(t) + 0.75(t)2 2.11 x 10-3(t)3,
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FIGURE 17 Number of platelets constituting an average single growing
thrombus and average thrombus volume as a function of time and wall
shear rate. The experimental data for the number of platelets were
curve-fitted with the following cubic polynomials: Pl1 = - 7.62 + 0.40t
+ 7.50 x 0I2t2 - 2.11 x 10-4t3, R2 = 0.99; Pg - -21.80 + 4.71t -
5.22 x 10-2t2 + 2.59 x 10-4t3, R2 - 0.90; Pl0 - 17.50 - 2.38t + 4.15
x 10-2t2 - 1.10 x 10-4t3, R2 - 0.91, where P and t represent,
resepctively, the number of platelets per thrombus and the time in
seconds, and R2 is the coefficient of determination, defined as R2 =
(S, - S,)/St, where St is the total sum of the squares around the mean,
and Sr is the sum of the squares of the residuals around the regression
line. The coefficients in the above polynomials have to be multiplied by
10 to obtain the polynomials curve-fitting the average thrombus volume
data.
with t representing time in seconds. That equation is solved numerically
for a feasible time root, and t, in this case, is found to be 55.5 s. The
thrombus growth rate, at that specific time, may now be estimated by
evaluating the time derivative of the corresponding polynomial repre-
senting the data of Fig. 17 at 1,500 s-', as following:
[d(plt)] 0.40 + 2(7.50 x 10-2)(t)
dt Jt55.5
- 3(2.1 1 x 10-4)(t)2 = 6.80 pIt/s.
One may now calculate the ADP flux over a thrombus surface area of
(2)(7r)(l0)2 or 628.3 OMm2, as:
Flux (ADP) (6.80 plt/s)(3 x 10'1 mol/plt)(O.80)
~628.3 4tM2
= 25.80 x 10-' mol/Am2 s.
TxA2 flux
Because TxA2 is generated enzymatically within the platelet, its flux
depends primarily on the number of platelets composing the thrombus,
rather than on the thrombus growth rate. It is also assumed that its
intracellular precursor, arachidonic acid, is present in excess, therefore
not limiting TxA2 metabolism. Furthermore, because the internal
diffusion of TxA2 from the thrombus core to the outside fluid was not
taken into account when estimating the wall fluxes of that compound,
the calculated concentration profiles represent upper bounds on those
observed experimentally. From the measurements of reference 52 and
calculations similar to those of reference 15, TxA2 generation rate per
platelet is estimated to be 0.95 x 10-° mol/s. The model thrombus size
at t = 55.5 s is computed by evaluating the polynomial curve-fitting the
data of Fig. 17 at 1,500 s-', as following:
[No. platelets],-55.5 = -7.62 + 0.40(t) + 7.50 x 10-2(t)2
2.11 x 10-4(t)3 = 209.40 plt.
The TxA2 flux may now be calculated as:
Flux (TxA2) = (209.40 plt)(O.95 x 1020 mol/pit s)
628.3 AtM2
= 3.20 x 10-21 mol/ ,um2 s.
Table 3, for circular model thrombi, and Table 4, for rectangular ones,
summarize all experimentally derived data, including platelet-activat-
ing agent fluxes, the sizes and growth rates of model thrombi, and the
time roots as a function of wall shear rate and model thrombus size.
Reaction rate constants
The detailed calculations of the chemical reaction rate constant for the
nonenzymatic hydrolysis of TxA2 to TxB2 in aqueous medium are given
in reference 15. The value used is given in Table 1.
Inactivation of thrombin by AT Ill
Thrombin is inactivated, in the bulk phase, by the circulating AT III,
assumed to be present in excess around the thrombus ([AT III] >> [T],
where [AT 111] is the AT III molar concentration and [T] is the
thrombin molar concentration). The whole blood concentration of AT
III is -2.844 MM, assuming a plasma concentration of 29 mg/dl (9) and
an average hematocrit of 39.2%. The observed second order rate
constant, k", was measured in reference 53 to be 4.25 x 105 M' min-,
with a reaction rate equation of the form: -d[T]/dt kI[AT III] [T].
An observed pseudo-first order reaction rate constant, k' , may now be
estimated according to kb k4[AT III], and in the present case, turns
out to be 0.0201 s-'.
Inactivation of thrombin by AT III
in presence of heparin
Inhibition of thrombin by AT III is greatly accelerated in presence of
heparin. To fully investigate the inhibitory effect of heparin, we
performed calculations with two different heparin concentrations, the
experimentally used concentration and the concentration for maximum
rate of inhibition, as determined by the data in reference 25. Heparin,
with a specific activity of 300 USP U/mg, is used in concentration of 10
U/ml of blood in our experiments, which corresponds to a whole blood
concentration of 2.0833 gM. From Fig. 1 in reference 25, the observed
second order rate constant kA; is -0.25 x 109 M' min-' at that heparin
concentration. The observed pseudo first order rate constant, k' , may
be estimated as reported above and is found to be 11.85 s-'. From the
same figure in reference 25, the maximum rate of inhibition for that
reaction occurs at [heparin] 9.0 x 10-8 M, and with k;,4. - 2.68 x 109
M` min-' k' is 127.0 s-' in this case. All reaction rate constants are
summarized in Table 1.
Physical Parameters
All physical parameters were estimated as constant average quantities,
for a given wall shear rate, in our model. Assuming a homogeneous fluid,
most parameters were calculated on the basis of an average shear rate
(-k) across the channel, which, for a parabolic velocity profile, is given
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Those assumptions are justified, for the present model, by the facts that
the crowding of RBCs in the center of the vessel (rouleaux formation),
leading to a large plasmatic layer near the wall surface, and thereby to a
nonuniform cell distribution across the channel, occurs predominantly in
vessels of very small diameter. Also, the non-Newtonian behavior of
blood, another consequence of the nonuniform RBC distribution, which
can lead to a nonparabolic velocity profile, is important primarily at very
low shear rates (<100 s-l) (54).
Because it has been shown (55) that, in vessels with diameters smaller
than -500 zm, the average hematocrit in the tube, ht, is less than the
hematocrit of the entering fluid, h. (chosen arbitrarily as 40% here), a
phenomenon referred to as the F&hraeus effect, the magnitude of that
effect was estimated theoretically by the authors for the present model.
Based on Lih's model derived for a tube with a stepwise RBC distribu-
tion (54), and using, as a first approximation, Einstein's model for the
hematocrit-dependency of viscosity (54), h, was calculated to be 39.2%,
indicating that the Fahraeus effect is relatively weak in our model. That
value was used, however, in all subsequent calculations involving
hematocrit.
Because blood viscosity is known to be a weakly decreasing function of
shear rate (j' >100 s-') (56), an average viscosity was estimated at each
shear rate (see Table 2), using an equation derived by Quemada, that
represents the rheological properties of blood and related red cell
suspensions over a wide range of conditions (55).
Because the problem treated is essentially an isothermal one, with a
constant temperature of 370C, the density of blood was considered
constant at 1. 1064 g/cm3 in all calculations.
When RBCs are present in a nonuniform velocity field, such as exists
in parallel plate flow, the cells rotate, entraining the small fluid layers
surrounding the cells to rotate also. Those local secondary flows greatly
augment the effective diffusivities of cells and large molecular weight
species, particularly vWF multimers and thrombin, when compared to
Brownian diffusion alone. Keller ( 11) has developed a model which gives
the effective diffusion coefficient, D,e as:
De = Db + Di, (C2)
where Db is the Brownian molecular diffusion coefficient (see Table 1),
and Di is the rotation-induced diffusion coefficient (see Table 2), given
by:
Di = 0.1 8 2iwaii, (C3)
where 6 is the equivalent RBC radius.
Because the thrombogenesis process occurs predominantly near the
wall surface, where RBC concentration is low, it is postulated that the
enhanced diffusivity is due primarily to RBC rotation rather than to
interparticle collision, which may be the prevailing mechanism in the
bulk. For the same reason, the wall shear rate -',. rather than the
average shear rate (e') is used in Eq. C3. The parameters for the
platelet-activating agents and the chemical reactions, and the shear
rate-dependent physical parameters are summarized in Tables 1 and 2,
respectively.
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